Given the current understanding of the molecular landscape of PMP and the presence of an immunosuppressive tumor microenvironment associated with KRAS and GNAS mutations in other tumor types, this study aimed to investigate the potential role of immunosuppressive factors in PMP, allowing tumor cells to evade immune surveillance. The gene discussed is GNAS; the disease is neoplasm.